EDIT vs ULTA · rev $32.3M vs P/E 17, rev $11.30B
Editas Medicine Inc (EDIT) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ULTA revenue for 2025-02-01 was $11.30B. Net income was $1.20B. Revenue was up 0.8% from 2024-02-03 to 2025-02-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
EDIT currently screens at market cap $375.2M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the EDIT and ULTA stock pages for the full models.
Not investment advice.